BioLineRx (BLRX) Reports In-Line Q1 EPS

BioLineRx (NASDAQ: BLRX) reported Q1 EPS of $0.00. Revenue for the quarter came in at $480 thousand.

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

You May Also Be Interested In

• Securitize Corp (SECZ) PT Raised to $12 at StoneX on 'Innovation Exemption'
• Magnitude International regains Nasdaq filing compliance
• StoneX Reiterates Buy Rating on Kamada Ltd. (KMDA) on Increased Demand for Anti-Rabies Treatment